Cargando…

Primary vitreoretinal lymphoma

Primary vitreoretinal lymphoma (PVRL) is an uncommon, but potentially fatal intraocular malignancy, which may occur with or without primary central nervous system lymphoma (PCNSL). Considered to be a subset of PCNSL, it is mostly of diffuse large B-cell type. The diagnosis of PVRL poses a challenge...

Descripción completa

Detalles Bibliográficos
Autores principales: Mulay, Kaustubh, Narula, Ritesh, Honavar, Santosh G
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4448230/
https://www.ncbi.nlm.nih.gov/pubmed/25971162
http://dx.doi.org/10.4103/0301-4738.156903
_version_ 1782373673618898944
author Mulay, Kaustubh
Narula, Ritesh
Honavar, Santosh G
author_facet Mulay, Kaustubh
Narula, Ritesh
Honavar, Santosh G
author_sort Mulay, Kaustubh
collection PubMed
description Primary vitreoretinal lymphoma (PVRL) is an uncommon, but potentially fatal intraocular malignancy, which may occur with or without primary central nervous system lymphoma (PCNSL). Considered to be a subset of PCNSL, it is mostly of diffuse large B-cell type. The diagnosis of PVRL poses a challenge not only to the clinician, but also to the pathologist. Despite aggressive treatment with chemotherapy and/or radiotherapy, relapses or CNS involvement are common.
format Online
Article
Text
id pubmed-4448230
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Medknow Publications & Media Pvt Ltd
record_format MEDLINE/PubMed
spelling pubmed-44482302015-06-11 Primary vitreoretinal lymphoma Mulay, Kaustubh Narula, Ritesh Honavar, Santosh G Indian J Ophthalmol Symposium Primary vitreoretinal lymphoma (PVRL) is an uncommon, but potentially fatal intraocular malignancy, which may occur with or without primary central nervous system lymphoma (PCNSL). Considered to be a subset of PCNSL, it is mostly of diffuse large B-cell type. The diagnosis of PVRL poses a challenge not only to the clinician, but also to the pathologist. Despite aggressive treatment with chemotherapy and/or radiotherapy, relapses or CNS involvement are common. Medknow Publications & Media Pvt Ltd 2015-03 /pmc/articles/PMC4448230/ /pubmed/25971162 http://dx.doi.org/10.4103/0301-4738.156903 Text en Copyright: © Indian Journal of Ophthalmology http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Symposium
Mulay, Kaustubh
Narula, Ritesh
Honavar, Santosh G
Primary vitreoretinal lymphoma
title Primary vitreoretinal lymphoma
title_full Primary vitreoretinal lymphoma
title_fullStr Primary vitreoretinal lymphoma
title_full_unstemmed Primary vitreoretinal lymphoma
title_short Primary vitreoretinal lymphoma
title_sort primary vitreoretinal lymphoma
topic Symposium
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4448230/
https://www.ncbi.nlm.nih.gov/pubmed/25971162
http://dx.doi.org/10.4103/0301-4738.156903
work_keys_str_mv AT mulaykaustubh primaryvitreoretinallymphoma
AT narularitesh primaryvitreoretinallymphoma
AT honavarsantoshg primaryvitreoretinallymphoma